VS

Vikram Sharma

Active Director Director DIN 07512651
DIN 07512651 First appointment May 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2016
Shareholding value •••• Premium profile

About Vikram Sharma

Data last updated:

Vikram Sharma is a Director at Winvet Pharma Private Limited (since 2016). The company operates in Pharma. Winvet Pharma Private Limited reported revenue of ₹61.5 Lakh (FY 2025).

DIN 07512651
Primary Designation Director
Industry Pharma
First Appointment 23 May 2016
Oldest Company Age 10 yrs
Largest company Winvet Pharma Private Limited · ₹61.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Winvet Pharma Private Limited U74999RJ2016PTC055019
Director23 May 20162016₹61.5 Lakh (FY 2025)Active

Board colleagues of Vikram Sharma

NameDINCompanyDesignation
Hari Om07512652Winvet Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Winvet Pharma Private Limited
Premium access

Shareholding and investment profile for Vikram Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vikram Sharma

Vikram Sharma currently holds 1 directorship: Winvet Pharma Private Limited (Director, since 23 May 2016, revenue ₹61.5 Lakh (FY 2025)).

Vikram Sharma was first appointed on 23 May 2016 as Director at Winvet Pharma Private Limited.

The current boards of Vikram Sharma's companies include Hari Om (Winvet Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available